BiotechTube
Home/AdipoPharma/Michael J. Fare
MJ

Michael J. Fare

Chief Operating Officer

AdipoPharma

Therapeutic Areas

Metabolic DiseaseType 2 DiabetesInsulin Resistance

AdipoPharma Pipeline

DrugIndicationPhase
PATASType 2 Diabetes, Insulin Resistance, and Associated Comorbidities (e.g., liver steatosis/fibrosis)Pre-clinical

Leadership Team at AdipoPharma

VM
Vincent Marion
Founder, President & CEO
CP
Catherine Perot
Chief Financial Officer
TG
Tarekegn G. Hiwot
Chief Medical Officer
VB
Virginie Barthel
Director of Clinical Operations
View full AdipoPharma profile